Clinical Trials in San Diego

Showing 7061-7080 of 11,146 trials

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

NCT02556177

This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

ConcussionTraumatic Brain Injury

GE Healthcare477 participantsStarted Nov 2015

San Diego, California, United States • San Francisco, California, United States • Miami, Florida, United States +4 more locations

COMPLETEDPhase 4< 1 mile

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

NCT01842581

The purpose of the study is to evaluate if rifaximin alone or rifaximin plus lactulose delays the onset of hepatic encephalopathy (HE) in participants with cirrhosis who have had a previous episode of HE.

Hepatic EncephalopathyCirrhosis

Bausch Health Americas, Inc.222 participantsStarted Jan 2013

Phoenix, Arizona, United States • Coronado, California, United States • Fresno, California, United States +40 more locations

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

Find Trials by Condition in San Diego

Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections

Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Safety and Efficacy Study of Botox in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

A Study in Advanced Cancer

A Study LY2228820 for Recurrent Ovarian Cancer

The Patient-Reported Outcomes Project of HCV-TARGET

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia